Last updated: October 14, 2024
Sponsor: University Hospital Erlangen
Overall Status: Active - Recruiting
Phase
N/A
Condition
Polycystic Ovarian Syndrome
Reproductive Health
Treatment
N/AClinical Study ID
NCT06642831
22-114-B
Ages 15-25 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female subjects age 15-25 years
Signed written informed consent
Exclusion
Exclusion Criteria:
Less than 1 years from onset of menarche
Use of hormonal contraceptives
Documented ongoing pregnancy
Major ovarian abnormalities, including subject with only one ovary, cysts and solidmasses > 2 cm as detected by transvaginal ultrasound
Malignancy ( documented malignancy, documentation of current radiation therapy orchemotherapy in medical record)
Study Design
Total Participants: 380
Study Start date:
January 31, 2023
Estimated Completion Date:
March 31, 2027
Study Description
Connect with a study center
Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany
Erlangen, 91054
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.